News
Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
In combination with established tumor markers, EDTA-plasma Tumor M2-PK ... PK testing is a good noninvasive screening parameter for colorectal cancer with a reported sensitivity of 68.8-91.0% ...
The aim is to identify colorectal cancer subtypes so that these can then be treated in a customized manner. Two informative markers are microsatellite instability (MSI) and tumor-infiltrating ...
Karen Kennerley / SWNS A special education teacher and mom of two is trying to raise funds or a last-chance treatment to stop the spread of stage 4 colon cancer ... revealed a tumor in her ...
Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...
CytoDyn has received FDA clearance to initiate a Phase II study of leronlimab in patients with relapsed or refractory micro-satellite stable colorectal ... targets CCR5 marker on the tumor.
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results